Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 345.00
Bid: 330.00
Ask: 360.00
Change: 0.00 (0.00%)
Spread: 30.00 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 345.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' option interests

31 Mar 2015 12:44

RNS Number : 0101J
Cropper(James) PLC
31 March 2015
 

31 March 2015

James Cropper plc

(the "Company")

 

Directors' option interests

 

The Company provides the following update of the interest of the directors in options over ordinary shares of 25p each in the Company ("Options").

 

The trustees of the James Cropper Employee Trust of James Cropper EBT Ltd approved grant awards to the following directors under the terms of The James Cropper Plc 2008 Long Term Incentive Plan (the "LTIP" or the "Plan"), as set out below.

 

Grant date

20/08/2012

16/11/2012

23/07/2013

21/01/2014

04/08/2014

Award ref price

184.0p

174.65p

253.4p

361.4p

382.8p

 

Options vested

 

Total LTIP Options

Director

MAJ Cropper

4,673

6,022

10,695

IM Maddock

1,808 *

7,868

9,676

M Thompson

13,000 *

11,601

7,868

32,469

KD Watson

2,252

8,832

11,084

PI Wild

19,324

32,796

22,242

74,362

PJ Willink

16,000

10,978

7,868

34,846

* LTIP Options granted prior to appointment to Board

 

The LTIP Options are subject to the achievement of pre-determined performance conditions and become exercisable at the end of a three year holding period from the date of the award. Further details are set out in the appendix below.

 

In addition, the following directors hold Options under the Company's save-as-you-earn ("SAYE") scheme, exercisable at 199.52p per share within six month of maturity, as set out below.

 

Term

(from 1 September 2013)

3.25 years

5.25 years

Total SAYE Options

Director

IM Maddock

4,360

4,360

PI Wild

4,510

4,510

PJ Willink

902

902

 

Enquiries:

David Carey, Company Secretary

Robert Finlay, David Coaten

James Cropper PLC (AIM:CRPR)

Westhouse Securities Limited

Tel: +44 (0) 1539 722002

Tel: +44 (0) 207 601 6100

www.cropper.com

www.westhousesecurities.com

 

Appendix - Long-Term Incentive Plan performance conditions

 

Under the Plan, awards to acquire ordinary shares in the Company can be made to executive directors and employees of the Company and its subsidiaries selected by the Remuneration Committee.

Awards made during the financial year to 28 March 2015 under the Plan to executive directors were as follows:

Number at 29 March 2014

Number granted in period

Mid-market price (£) of options awarded

Number exercised in period

Options lapsed in period

Number at 28 March 2015

P I Wild

52,120

22,242

£3.828

-

-

74,362

M A J Cropper

4,673

6,022

£3.828

-

-

10,695

J M Denman*

39,601

-

-

-

-

39,601

-

N A Read*

39,029

-

-

39,029

-

P J Willink

38,978

7,868

£3.828

-

12,000

34,846

I M Maddock

1,808

7,868

£3.828

-

-

9,676

M Thompson

34,601

7,868

£3.828

-

10,000

32,469

K D Watson

2,252

8,832

£3.828

-

-

11,084

* previous directors

The number of options that can be awarded to any participant in a financial year under the Plan, determined by reference to Company's 20 day average mid-market share price at the time of the award, is limited to a maximum of 50% of the participant's basic salary.

The LTIP awards are subject to the achievement of certain performance conditions, specific to each director, as set out below:

Earnings per share conditions

EBITDA targets conditions

Percentage of Award

Percentage of Award

P I Wild

60%

40%

M A J Cropper

60%

40%

P J Willink

100%

-

I M Maddock

100%

-

M Thompson

100%

-

K D Watson

100%

-

 

(i) Earnings per share conditions

- Awards will vest in full on the third anniversary of the Award provided the growth in the Company's earnings per share, adjusted for IFRS pension adjustments, between the preceding financial year end when the award was granted and the preceding financial year end when the grant is vested exceed the increase in retail price index plus 10% per annum;

 

- Awards will vest at 10% on the third anniversary of the Award if the growth in the Company's earnings per share, adjusted for IFRS pension adjustments, between the preceding financial year end when the award was granted and the preceding financial year end when the grant is vested exceed the increase in retail price index plus 2.5% per annum;

 

- Awards will vest proportionally between 10% and 100% on the third anniversary of the Award if the growth in the Company's earnings per share, adjusted for IFRS adjustments, between the preceding financial year end when the award was granted and the preceding financial year end when the grant is vested exceed the increase in retail price index by more than 2.5% but less than 10% per annum; and

 

- Awards will lapse on the third anniversary of the Award if the growth in the Company's earnings per share, adjusted for IFRS pension adjustments, between the preceding financial year end when the award was granted and the preceding financial year end when the grant is vested, does not exceed the increase in retail price plus 2.5% per annum.

 

(ii) EBITDA target conditions

- Awards will vest in full on the third anniversary of the Award if the third year EBITDA target as set out in the Company's 3 Year Business Plan approved in the year that the award was granted has been met or exceeded;

 

- Awards will vest at 30% on the third anniversary of the Award if at least 95% but less than 100% of the third year EBITDA target as set out in the Company's 3 Year Business Plan approved in the year that the award was granted has been met or exceeded;

 

- Awards will vest at 20% on the third anniversary of the Award if a least 90% but less than 95% of the EBITDA target as set out in the Company's 3 Year Business Plan approved in the year that the award was granted has been met or exceeded; and

 

- Awards will lapse on the third anniversary of the Award if less than 90% of the EBITDA target as set out in the Company's 3 Year Business Plan approved in the year that the award was granted has been achieved.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFFLFXEXFZBBX
Date   Source Headline
30th Apr 20247:00 amRNSFull Year Trading Update
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update
12th Jan 20247:00 amRNSDirectorate Update
21st Dec 20233:33 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSGrant of Awards under Long Term Incentive Plan
27th Nov 20237:00 amRNSBoard Appointment
24th Nov 20232:30 pmRNSDirectorate Change
9th Nov 20237:00 amRNSInterim Results
26th Oct 20237:00 amRNSNotice of Interim Results
26th Sep 20232:50 pmRNSResult of Annual General Meeting
26th Sep 20237:00 amRNSAGM Trading Update
4th Sep 20237:00 amRNSNotice of AGM
31st Aug 20237:00 amRNSInnovative production unit for green hydrogen
29th Aug 202312:43 pmRNSDividend Declaration
24th Aug 20237:00 amRNSFull Year Results
10th Aug 20237:00 amRNSNotice of Full Year Results
14th Jun 20237:00 amRNSDirectorship Change
7th Jun 20237:00 amRNSTFP HYDROGEN ANNOUNCES EXPANSION IN NORTH AMERICA
21st Apr 20235:18 pmRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSTrading Update and Overview of Strategy
14th Feb 202312:00 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 20239:45 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:48 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSHalf Year Trading Update
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
12th Sep 202211:03 amRNSDirector/PDMR Shareholding
2nd Sep 20224:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorship Change
5th Aug 202211:45 amRNSDirector/PDMR Shareholding
27th Jul 202211:00 amRNSQ1 Trading Update and AGM Statement
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:34 amRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
23rd Jun 202210:25 amRNSNotice of AGM and Annual Report & Accounts
21st Jun 20227:00 amRNSFinal Results
12th May 202212:01 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading Update
26th Jan 20222:30 pmRNSDirector/PDMR Shareholding
21st Jan 202212:15 pmRNSDirector/PDMR Shareholding
20th Jan 202210:30 amRNSDirectorate Change
12th Jan 20222:00 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.